CORD-19:5e8abc62533a447422d5ead64d4ae4991cc99052 / 1862-2145 JSONTXT

Annnotations TAB JSON ListView MergeView

CORD-PICO

Id Subject Object Predicate Lexical cue
p1_all10 53-56 Intervention denotes XKB
p1_all11 116-181 Outcome denotes area under the plasma concentration-time curve (AUC) of midazolam
p1_all12 218-267 Outcome denotes plasma clearance and AUC ratio of 1′-OH-midazolam
p2_i6 53-56 Pharmacological denotes XKB
p2_i7 172-181 Pharmacological denotes midazolam
p2_i8 273-282 Pharmacological denotes midazolam
p2_o11 116-181 Physical denotes area under the plasma concentration-time curve (AUC) of midazolam
p2_o11 218-267 Physical denotes plasma clearance and AUC ratio of 1′-OH-midazolam

CORD-19-Sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T13 0-283 Sentence denotes The in vivo study showed that oral administration of XKB at 14 mg/kg to rats for 8 days significantly increased the area under the plasma concentration-time curve (AUC) of midazolam, with a concomitant decrease in the plasma clearance and AUC ratio of 1′-OH-midazolam over midazolam.
T88805 0-283 Sentence denotes The in vivo study showed that oral administration of XKB at 14 mg/kg to rats for 8 days significantly increased the area under the plasma concentration-time curve (AUC) of midazolam, with a concomitant decrease in the plasma clearance and AUC ratio of 1′-OH-midazolam over midazolam.